Cytokine modulation in acute pancreatitis

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 8, Issue 3, 2001, Pages 195-203

  Yamauchi, Jun Ichiro ^a   Shibuya, Kazuhiko ^a   Sunamura, Makoto ^a   Arai, Kousuke ^a   Shimamura, Hiromune ^a   Motoi, Fuyuhiko ^a   Takeda, Kazunori ^a   Matsuno, Seiki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute pancreatitis; Chemokine; Cytokine

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL; HOSPITALIZATION; HUMAN; METABOLISM; MOUSE; PANCREATITIS; PREDICTION AND FORECASTING; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; CHEMOKINES; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MICE; PANCREATITIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035223409     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340170016     Document Type: Article

References (124)

1. Takeda K, Matsuno S, Sunamura M, Kobari M (1998) Surgical aspects and management of acute necrotizing pancreatitis: recent results of a cooperative national survey in Japan. Pancreas 16:316-322
2. Sunamura M, Lozonschi L, Takeda K, Kobari M, Matsuno S (1998) Criteria for diagnosis of acute pancreatitis in Japan and clinical implications. Pancreas 16:243-249
3. Hofbauer B, Saluja AK, Lerch MM, Bhagat L, Bhatia M, Lee HS, Frossard JL, Adler G, Steer ML (1998) Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol 275:G352-362
4. Otani T, Chepilko SM, Grendell JH, Gorelick FS (1998) Codistribution of TAP and the granule membrane protein GRAMP-92 in rat caerulein-induced pancreatitis. Am J Physiol 275:G999-G1009
5. Tran DD, Cuesta MA (1992) Evaluation of severity in patients with acute pancreatitis. Am J Gastroenterol 87:604-608
6. Neoptolemos JP, Raraty M, Finch M, Sutton R (1998) Acute pancreatitis: the substantial human and financial costs. Gut 42: 886-891
7. Kusterer K, Poschmann T, Friedemann A, Enghofer M, Zendler S, Usadel KH (1993) Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol 265:G165-171
8. Klar E, Schratt W, Foitzik T, Buhr H, Herfarth C, Messmer K (1994) Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotizing pancreatitis in rabbit pancreas. Dig Dis Sci 39:2639-2644
9. Menger MD, Bonkhoff H, Vollmar B (1996) Ischemia-reperfusion-induced pancreatic microvascular injury. An intravital fluorescence microscopic study in rats. Dig Dis Sci 41:823-830
10. Yamauchi J, Sunamura M, Shibuya K, Takeda K, Kobari M, Matsuno S (1999) A novel diamino-pyridine derivative prevents excessive leukocyte infiltration in aggravation of acute necrotizing pancreatitis. Digestion 60:40-46
11. Fink GW, Norman JG (1996) Intrapancreatic interleukin-1beta gene expression by specific leukocyte populations during acute pancreatitis. J Surg Res 63:369-373
12. Fink GW, Norman JG (1997) Specific changes in the pancreatic expression of the interleukin 1 family of genes during experimental acute pancreatitis. Cytokine 9:1023-1027
13. Bhatia M, Saluja AK, Hofbauer B, Lee HS, Frossard JL, Steer ML (1998) The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. Int J Pancreatol 24:77-83
14. Kingsnorth A (1997) Role of cytokines and their inhibitors in acute pancreatitis. Gut 40:1-4
15. Gross V, Andreesen R, Leser HG, Ceska M, Liehl E, Lausen M, Farthmann EH, Scholmerich J (1992) Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 22:200-203
16. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW (1993) Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 34:41-45
17. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, Ruckauer K, Andreesen R, Farthmann EH, Scholmerich J (1991) Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 101:782-785
18. Pezzilli R, Billi P, Miniero R, Fiocchi M, Cappelletti O, Morselli-Labate AM, Barakat B, Sprovieri G, Miglioli M (1995) Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 40:2341-2348
19. Montravers P, Chollet-Martin S, Marmuse JP, Gougerot-Pocidalo MA, Desmonts JM (1995) Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis. Am J Respir Crit Care Med 152:1527-1533
20. de Beaux AC, Ross JA, Maingay JP, Fearon KC, Carter DC (1996) Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg 83:1071-1075
21. McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN (1996) Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 83:919-923
22. Frossard JL, Saluja A, Bhagal L, Lee HS, Bhatia M, Hofbauer B, Steer ML (1999) The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 116:694-701
23. Lundberg AH, Granger N, Russell J, Callicutt S, Gaber LW, Kotb M, Sabek O, Gaber AO (2000) Temporal correlation of tumor necrosis factor-alpha release, upregulation of pulmonary ICAM-1 and VCAM-1, neutrophil sequestration, and lung injury in diet-induced pancreatitis. J Gastrointest Surg 4:248-57
24. Lundberg AH, Granger DN, Russell J, Sabek O, Henry J, Gaber L, Kotb M, Gaber AO (2000) Quantitative measurement of P-and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Ann Surg 231:213-222
25. Zaninovic V, Gukovskaya AS, Gukovsky I, Mouria M, Pandol SJ (2000) Cerulein upregulates ICAM-1 in pancreatic acinar cells, which mediates neutrophil adhesion to these cells. Am J Physiol 279:G666-676
26. Grewal HP, Kotb M, el Din AM, Ohman M, Salem A, Gaber L, Gaber AO (1994) Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 115:213-221
27. Hughes CB, Gaber LW, Kotb M, Mohey el-Din AB, Pabst M, Gaber AO (1995) Induction of acute pancreatitis in germ-free rats: evidence of a primary role for tumor necrosis factor-alpha. Surgery 117:201-205
28. Grewal HP, Mohey el Din A, Gaber L, Kotb M, Gaber AO (1994) Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg 167:214-218
29. Hughes CB, Gaber LW, Mohey el-Din AB, Grewal HP, Kotb M, Mann L, Gaber AO (1996) Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg 62:8-13
30. Hughes CB, Grewal HP, Gaber LW, Kotb M, el-din AB, Mann L, Gaber AO (1996) Anti-TNF alpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg 171:274-280
31. Hughes CB, el-Din AB, Koth M, Gaber LW, Gaber AO (1996) Calcium channel blockade inhibits release of TNF alpha and improves survival in a rat model of acute pancreatitis. Pancreas 13:22-28
32. Norman JG, Fink GW, Messina J, Carter G, Franz MG (1996) Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 120:515-521
33. Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR Jr (1995) Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117:648-565
34. Norman JG, Franz MG, Fink GS, Messina J, Fabri PJ, Gower WR, Carey LC (1995) Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 221: 625-631; discussion 631-634
35. Tanaka N, Murata A, Uda K, Toda H, Kato T, Hayashida H, Matsuura N, Mori T (1995) Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med 23:901-908
36. Norman J, Yang J, Fink G, Carter G, Ku G, Denham W, Livingston D (1997) Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokine Res 17:113-118
37. Norman JG, Fink G, Franz M, Guffey J, Carter G, Davison B, Sexton C, Glaccum M (1996) Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg 223:163-169
38. Denham W, Yang J, Fink G, Denham D, Carter G, Ward K, Norman J (1997) Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology 113:1741-1746
39. Guice KS, Oldham KT, Remick DG, Kunkel SL, Ward PA (1991) Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. J Surg Res 51:495-499
40. Denham W, Fink G, Norman J (1997) Interleukin-1 and tumor necrosis factor cannot initiate colocalization of pancreatitis in vitro or in the perfused human pancreas. Surg Forum 48:181
41. Denham W, Yang J, Fink G, Denham D, Carter G, Bowers V, Norman J (1998) TNF but not IL-1 decreases pancreatic acinar cell survival without affecting exocrine function: a study in the perfused human pancreas. J Surg Res 74:3-7
42. Steinberg W, Tenner S (1994) Acute pancreatitis. N Engl J Med 330:1198-1210
43. Hughes CB, Henry J, Kotb M, Lobaschevsky A, Sabek O, Gaber AO (1995) Up-regulation of TNF alpha mRNA in the rat spleen following induction of acute pancreatitis. J Surg Res 59:687-693
44. Norman JG, Fink GW, Franz MG (1995) Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 130:966-970
45. Denham W, Yang J, Norman J (1997) Evidence for an unknown component of pancreatic ascites that induces adult respiratory distress syndrome through an interleukin-1 and tumor necrosis factor-dependent mechanism. Surgery 122:295-301
46. Imrie CW, Ferguson JC, Murphy D, Blumgart LH (1977) Arterial hypoxia in acute pancreatitis. Br J Surg 64:185-188
47. Renner IG, Savage WT 3d, Pantoja JL, Renner VJ (1985) Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig Dis Sci 30:1005-1018
48. Denham W, Yang J, Wang H, Botchkina G, Tracey KJ, Norman J (2000) Inhibition of p38 mitogen-activated protein kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome. Crit Care Med 28:2567-2572
49. Jatfray C, Yang J, Carter G, Mendez C, Norman J (2000) Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome. Surgery 128:225-231
50. Gukovskaya AS, Gukovsky I, Zaninovic V, Song M, Sandoval D, Gukovsky S, Pandol SJ (1997) Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 100:1853-1862
51. Malka D, Vasseur S, Bodeker H, Ortiz EM, Dusetti NJ, Verrando P, Dagorn JC, Iovanna JL (2000) Tumor necrosis factor alpha triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology 119:816-828
52. de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC (1996) Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 83:349-353
53. Brivet FG, Emilie D, Galanaud P (1999) Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 27:749-755
54. Heresbach D, Letourneur JP, Bahon I, Pagenault M, Guillou YM, Dyard F, Fauchet R, Malledant Y, Bretagne JF, Gosselin M (1998) Value of early blood Th-1 cytokine determination in predicting severity of acute pancreatitis. Scand J Gastroenterol 33:554-560
55. Hirota M, Nozawa F, Okabe A, Shibata M, Beppu T, Shimada S, Egami H, Yamaguchi Y, Ikei S, Okajima T, Okamoto K, Ogawa M (2000) Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 21:141-146
56. Aderka D (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7:231-240
57. Douni E, Kollias G (1998) A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R. J Exp Med 188:1343-1352
58. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, Ruckauer K, Andreesen R, Farthmann EH, Scholmerich J (1991) Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 101:782-785
59. Viedma JA, Perez-Matco M, Dominguez JE, Carballo F (1992) Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 33:1264-1267
60. Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254
61. Biffl WL, Moore EE, Moore FA, Peterson VM (1996) Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 224:647-664
62. Inagaki T, Hoshino M, Hayakawa T, Ohara H, Yamada T, Yamada H, Iida M, Nakazawa T, Ogasawara T, Uchida A, Hasegawa C, Miyaji M, Takeuchi T (1997) Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas 14:1-8
63. Pezzilli R, Billi P, Miniero R, Fiocchi M, Cappelletti O, Morselli-Labate AM, Barakat B, Sprovieri G, Miglioli M (1995) Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 40:2341-2348
64. Norman J (1998) The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 175:76-83
65. Heresbach D, Letourneur JP, Bahon I, Pagenault M, Guillou YM, Dyard F, Fauchet R, Malledant Y, Bretagne JF, Gosselin M (1998) Value of early blood Th-1 cytokine determination in predicting severity of acute pancreatitis. Scand J Gastroenterol 33:554-560
66. Mayer J, Rau B, Gansauge F, Beger HG (2000) Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 47:546-552
67. Blanchard JA 2nd, Barve S, Joshi-Barve S, Talwalker R, Gates LK Jr (2000) Cytokine production by CAPAN-1 and CAPAN-2 cell lines. Dig Dis Sci 45:927-932
68. Baggiolini M, Loetscher P, Moser B (1995) Interleukin-8 and the chemokine family. Int J Immunopharmacol 17:103-108
69. Gross V, Leser HG, Heinisch A, Scholmerich J (1993) Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 40:522-530
70. Formela LJ, Galloway SW, Kingsnorth AN (1995) Inflammatory mediators in acute pancreatitis. Br J Surg 82:6-13
71. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG (1997) The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 41:832-840
72. Kingsnorth AN, Galloway SW, Formela LJ (1995) Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 82: 1414-1420
73. Powell JJ, Murchison JT, Fearon KC, Ross JA, Siriwardena AK (2000) Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis. Br J Surg 87:1375-1381
74. Osman MO, Kristensen JU, Jacobsen NO, Lausten SB, Deleuran B, Deleuran M, Gesser B, Matsushima K, Larsen CG, Jensen SL (1998) A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits. Gut 43:232-239
75. Bhatia M, Brady M, Zagorski J, Christmas SE, Campbell F, Neoptolemos JP, Slavin J (2000) Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut 47:838-844
76. van Laethem JL, Deviere J, Resibois A, Rickaert F, Vertongen P, Ohtani H, Cremer M, Miyazono K, Robberecht P (1995) Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 108:1873-1881
77. Kusske AM, Rongione AJ, Ashley SW, McFadden DW, Reber HA (1996) Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 120:284-288
78. Rongione AJ, Kusske AM, Reber HA, Ashley SW, McFadden DW (1997) Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis. J Gastrointest Surg 1: 159-166
79. Gloor B, Todd KE, Lane JS, Rigberg DA, Reber HA (1998) Mechanism of increased lung injury after acute pancreatitis in IL-10 knockout mice. J Surg Res 80:110-114
80. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr (1999) Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 274:31868-31874
81. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW (1997) Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 112:960-967
82. Osman MO, Jacobsen NO, Kristensen JU, Deleuran B, Gesser B, Larsen CG, Jensen SL (1998) IT 9302, a synthetic interleukin-10 agonist, diminishes acute lung injury in rabbits with acute necrotizing pancreatitis. Surgery 124:584-592
83. Pezzilli R, Billi P, Miniero R, Barakat B (1997) Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci 42:1469-1472
84. Washington K, Gossage DL, Gottfried MR (1994) Pathology of the pancreas in severe combined immunodeficiency and DiGeorge syndrome: acute graft-versus-host disease and unusual viral infections. Hum Pathol 25:908-914
85. Straumann A, Bauer M, Pichler WJ, Pirovino M (1998) Acute pancreatitis due to pyritinol: an immune-mediated phenomenon. Gastroenterology 115:452-454
86. Jaray J, Perner F, Alfoldy F, Onody K (1981) Mixed lymphocyte cultures (MLC) and acute pancreatitis after renal transplantation. Int Urol Nephrol 13:391-394
87. Kusske AM, Rongione AJ, Reber HA (1996) Cytokines and acute pancreatitis. Gastroenterology 110:639-642
88. Pezzilli R, Billi P, Gullo L, Beltrandi E, Maldini M, Mancini R, Incorvaia L, Miglioli M (1994) Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Digestion 55:268-273
89. Mayer J, Laine VJ, Rau B, Hotz HG, Foitzik T, Nevalainen TJ, Beger HG (1999) Systemic lymphocyte activation modulates the severity of diet-induced acute pancreatitis in mice. Pancreas 19:62-68
90. Curley P, Nestor M, Collins K, Saporoschetz I, Mendez M, Mannick JA, Rodrick ML (1996) Decreased interleukin-2 production in murine acute pancreatitis: potential for immunomodulation. Gastroenterology 110:583-588
91. Buchler MW, Gloor B, Muller CA, Friess H, Seiler CA, Uhl W (2000) Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 232:619-626
92. Widdison AL, Karanjia ND, Alvarez C, Reber HA (1992) Influence of levamisole on pancreatic infection in acute pancreatitis. Am J Surg 163:100-103
93. Christou NV, Meakins JL (1979) Neutrophil function in surgical patients: in vitro correlation of abnormal neutrophil chemotaxis by levamisole. Surgery 85:543-548
94. Meakins JL, Christou NV, Shizgal HM, MacLean LD (1979) Therapeutic approaches to anergy in surgical patients. Surgery and levamisole. Ann Surg 190:286-296
95. Osman MO, Jensen SL (1999) Acute pancreatitis: the pathophysiological role of cytokines and integrins. New trends for treatment? Dig Surg 16:347-362
96. Rollins BJ (1997) Chemokines. Blood 90:909-928
97. Murdoch C, Finn A (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95:3032-3043
98. Grady T, Liang P, Ernst SA, Logsdon CD (1997) Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 113:1966-1975
99. Andoh A, Takaya H, Saotome T, Shimada M, Hata K, Araki Y, Nakamura F, Shintani Y, Fujiyama Y, Bamba T (2000) Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology 119:211-219
100. Gerard C, Frossard JL, Bhatia M, Saluja A, Gerard NP, Lu B, Steer M (1997) Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest 100:2022-2027
101. Shibuya K, Motoi F, Mikami Y, Yamauchi J, Shimamura H, Sunamura M, Takeda K, Matsuno S (2000) Murine IL-10 gene transduction does not improve caerulein pancreatitis in mice (abstract). Pancreas 21:479
102. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel KP, Balk R, Allred R, et al. (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomixed, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 273:934-941
103. Cohen J, Carlet J (1996) INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med 24: 1431-1440
104. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fe fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334:1697-1702
105. Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Bruining HA, Otto C, Tobin E, Zwingelstein C, Lesslauer W, Leighton A (1997) p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277:1531-1538
106. Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, et al. (1994) Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 271:1836-1843
107. Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25:1115-1124
108. Matuschak GM (1996) Circulating cytokine concentrations and outcome prediction in intensive care unit patients: still the tip of the iceberg? Crit Care Med 24:1769-1771
109. Kingsnorth AN (1997) Early treatment with lexipafant, a platelet activating factor antagonist reduces mortality in acute pancreatitis: a double blind, randomized, placebo controlled study (abstract). Gastroenterology 112:453
110. Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ (1998) Early NF-kappa B activation is associated with hormone-induced pancreatitis. Am J Physiol 275:G1402-1414
111. Jaffray C, Yang J, Carter G, Mendez C, Norman J (2000) Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome. Surgery 128:225-231
112. Lernbecher T, Muller U, Wirth T (1993) Distinct NF-kappa B/ Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767-770
113. Grilli M, Chiu JJ, Lenardo MJ (1993) NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 143:1-62
114. 2+. Am J Physiol Cell Physiol 278:C344-351
115. Satoh A, Shimosegawa T, Fujita M, Kimura K, Masamune A, Koizumi M, Toyota T (2000) Inhibition of nuclear factor-kappa B activation improves the survival of rats with taurocholate pancreatitis. Gut 44:253-258
116. Dunn JA, Li C, Ha T, Kao RL, Browder W (1997) Therapeutic modification of nuclear factor kappa B binding activity and tumor necrosis factor-alpha gene expression during acute biliary pancreatitis. Am Surg 63:1036-1043
117. Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM (1999) NF-kappa B/Rel activation in cerulein pancreatitis. Gastroenterology 116:420-430
118. Wagner AC, Metzler W, Hofken T, Weber H, Goke B (1999) p38 map kinase is expressed in the pancreas and is immediately activated following cerulein hyperstimulation. Digestion 60:41-47
119. Schafer C, Ross SE, Bragado MJ, Groblewski GE, Ernst SA, Williams JA (1998) A role for the p38 mitogen-activated protein kinase/Hsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini. J Biol Chem 273:24173-24180
120. Blinman TA, Gukovsky I, Mouria M, Zaninovic V, Livingston E, Pandol SJ, Gukovskaya AS (2000) Activation of pancreatic acinar cells on isolation from tissue: cytokine upregulation via p38 MAP kinase. Am J Physiol Cell Physiol 279:C1993-2003
121. Grisham MB (2000) NF-kappa B activation in acute pancreatitis: protective, detrimental, or inconsequential? Gastroenterology 116:489-492
122. Smithies AM, Sargen K, Demaine AG, Kingsnorth AN (2000) Investigation of the interleukin 1 gene cluster and its association with acute pancreatitis. Pancreas 20:234-240
123. Stuber F, Petersen M, Bokelmann F, Schade U (1996) A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24:381-384
124. Fang XM, Schroder S, Hoeft A, Stuber F (1999) Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 27:1330-1334